Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)

BACKGROUND: This was the first large-scale prospective observational Japanese study evaluating the safety and efficacy of bevacizumab combined with paclitaxel and carboplatin for newly diagnosed advanced ovarian cancer. METHODS: Patients were prospectively enrolled in the primary analysis cohort if...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiyama, Shinichi, Kato, Kazuyoshi, Inokuchi, Yuki, Takano, Hirokuni, Matsumoto, Takashi, Hongo, Atsushi, Asai-Sato, Mikiko, Arakawa, Atsushi, Kamiura, Shoji, Tabata, Tsutomu, Takeshima, Nobuhiro, Sugiyama, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326987/
https://www.ncbi.nlm.nih.gov/pubmed/30030657
http://dx.doi.org/10.1007/s10147-018-1319-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326987/
https://www.ncbi.nlm.nih.gov/pubmed/30030657
http://dx.doi.org/10.1007/s10147-018-1319-y

Ejemplares similares